m
Recent Posts
Connect with:
Friday / March 5.
HomeminewsNew App Connects HCPs With Life Sciences

New App Connects HCPs With Life Sciences

MyVeeva for Doctors, a mobile application to make it easy for health care professionals (HCPs) to connect with life sciences, has been introduced in Australia. MyVeeva provides HCPs with key contacts, information, and services they need from across pharmaceutical and biotech companies and brands. Leading companies, including Boehringer Ingelheim (BI), GSK, Pfizer, Sanofi, and Sobi, are among the early adopters of the app.

“Fully leveraging the power of digital access allows us to deliver greater value for HCPs, helping them to transform the lives of the patients they treat,” said Marz Abdulrahman, customer business solutions, at BI Pharmaceuticals, Inc. “Digital solutions like MyVeeva for Doctors enables BI to make it easier to secure patient resources and connect HCPs to the people they need for collaboration in a single, go to place.”

Advanced search capabilities in MyVeeva for Doctors makes it simple to find a person, medicine, or company and connect directly with the right contacts such as reps and reimbursement specialists through compliant realtime messaging or online meetings. HCPs can quickly get information and patient resources or request services such as product samples.

“When getting the right people and resources is easy, more healthcare professionals will connect and interact more often,” said Peter Gassner, founder and CEO of Veeva. “Veeva is teaming with the industry to offer the MyVeeva for Doctors app so HCPs can get what they need to better serve patients, all in one convenient place.”

Visit www.myveeva.com. 

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.